It was unveiled in 2016 that CCR8 is specifically expressed on tumor-infiltrating regulatory T cells (TITRs) across a range of primary and metastatic human cancer types, including breast, lung, colon carcinoma, and melanoma. Here, CCR8 is linked to cancer.